CuraScientific Statistics
Total Valuation
CuraScientific has a market cap or net worth of 5,535. The enterprise value is 3.22 million.
| Market Cap | 5,535 |
| Enterprise Value | 3.22M |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CuraScientific has 5.53 billion shares outstanding.
| Current Share Class | 5.53B |
| Shares Outstanding | 5.53B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +431.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.00.
| PE Ratio | 0.00 |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.10 |
| EV / Sales | 3.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.01 |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.83 |
| Interest Coverage | -14.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -108.98% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 11.84% |
| Revenue Per Employee | 526,201 |
| Profits Per Employee | 16.85M |
| Employee Count | 2 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 62.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is -14.40, so CuraScientific's price volatility has been lower than the market average.
| Beta (5Y) | -14.40 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 23.40 |
| Average Volume (20 Days) | 50 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, CuraScientific had revenue of 1.05 million and earned 33.70 million in profits. Earnings per share was 0.05.
| Revenue | 1.05M |
| Gross Profit | -775,049 |
| Operating Income | -2.89M |
| Pretax Income | 33.70M |
| Net Income | 33.70M |
| EBITDA | -1.63M |
| EBIT | -2.89M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 40,911 in cash and 733,931 in debt, giving a net cash position of -693,020 or -0.00 per share.
| Cash & Cash Equivalents | 40,911 |
| Total Debt | 733,931 |
| Net Cash | -693,020 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -24.78M |
| Book Value Per Share | -0.01 |
| Working Capital | -24.98M |
Cash Flow
In the last 12 months, operating cash flow was -304,302 and capital expenditures -97,686, giving a free cash flow of -401,988.
| Operating Cash Flow | -304,302 |
| Capital Expenditures | -97,686 |
| Free Cash Flow | -401,988 |
| FCF Per Share | -0.00 |
Margins
Gross margin is -73.65%, with operating and profit margins of -275.07% and 3,201.80%.
| Gross Margin | -73.65% |
| Operating Margin | -275.07% |
| Pretax Margin | 3,201.80% |
| Profit Margin | 3,201.80% |
| EBITDA Margin | -154.60% |
| EBIT Margin | -275.07% |
| FCF Margin | n/a |
Dividends & Yields
CuraScientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23,019.63% |
| Shareholder Yield | n/a |
| Earnings Yield | 608,776.82% |
| FCF Yield | -7,262.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 24, 2023. It was a reverse split with a ratio of 0.002.
| Last Split Date | Apr 24, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.002 |
Scores
CuraScientific has an Altman Z-Score of -8.79. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.79 |
| Piotroski F-Score | n/a |